Skip to content
Sunday, November 8, 2026
ActiveTrend

The Zimbabwean Government Declines ‘Lopsided’ American Healthcare Assistance Deal Because of Data Fears

Medical funding image
The offered US funding was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a significant US health deal worth $367m (272 million pounds) over five years due to the United States' request for confidential information.

This move was revealed following a internal memorandum dated December was disclosed, revealing that President Emmerson Mnangagwa believed the agreement was "lopsided".

An official representative has since explained that the United States was demanding access to health data for scientific study and commercial purposes but was not willing to guarantee the benefits from future treatments.

"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has appealed for further talks to reach a deal acceptable to both sides so the country's vital HIV programme can proceed.

Wider Background

This development follows a comparable case in Kenya, where a high court halted a similar deal with the US after concerns were filed about the safety of citizens' medical information.

After returning to office recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).

USAID had overseen assistance for the American government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and responsibility.

According to statements, Sixteen nations in Africa have so far signed these new health pacts, constituting more than $18.3bn of fresh investment.

Details of the Declined Deal

The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this collaboration could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment via American-funded initiatives," Tremont commented.

However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".

"Our nation was requested to surrender its biological resources and data indefinitely, without any equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," Mangwana explained.

"In essence, our country would supply the basic resources for medical research without any certainty that the final treatments would be available to our citizens if a new disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further pointed out that the American exit from the global health body and its push of one-on-one deals were disrupting systems already established via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.

"This framework is designed to guarantee that when a nation provides its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the resources to develop them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," he added.

"We encourage further discussions with our US partners on how future collaboration might be arranged in a way that honours the independence and interests of both nations."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but urged that talks should continue since a large portion of the nation's Aids initiatives relied on international support.

"In cases where technical issues arise, including those involving information security or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," the group commented.

This impasse underscores the continuing debate between accepting much-needed international aid and safeguarding a country's data in an ever more data-driven world.

Written by

Tonya Garza

Certified personal trainer and nutritionist with over 10 years of experience helping clients achieve their fitness goals.

ActiveTrend

Type to search articles.